Table 2.
Demographic and Baseline Characteristics of the Patients
| Characteristic | No. (%) of Patients (n = 28) |
|
|---|---|---|
| Sex | ||
| Female | 15 (54) | |
| Male | 13 (46) | |
| Age, median (range), y | 71 (49–88) | |
| Race/ethnicity | ||
| White | 27 (96) | |
| Black | 1 (4) | |
| Non-Hispanic or non-Latino | 26 (93) | |
| Hispanic or Latino | 2 (7) | |
| Clinical melanoma subtype | ||
| Mucosal | 13 (46) | |
| Acral | 10 (36) | |
| Chronically sun-damaged | 5 (18) | |
| Increased lactate dehydrogenasea | 11 (39) | |
| ECOG performance status | ||
| 0 | 19 (68) | |
| 1 | 8 (28) | |
| 2 | 1 (4) | |
| Prior systemic regimens for metastatic disease | ||
| 0 | 7 (25) | |
| 1 | 14 (50) | |
| ≥2 | 7 (25) | |
Abbreviation: ECOG, Eastern Cooperative Oncology Group.
a
Indicates lactate dehydrogenase level of more than the upper limit of normal.